home / stock / dare / dare news


DARE News and Press, Dare Bioscience Inc. From 12/10/21

Stock Information

Company Name: Dare Bioscience Inc.
Stock Symbol: DARE
Market: NASDAQ
Website: darebioscience.com

Menu

DARE DARE Quote DARE Short DARE News DARE Articles DARE Message Board
Get DARE Alerts

News, Short Squeeze, Breakout and More Instantly...

DARE - Dare Bioscience gives back most of its strong gains from Tuesday's FDA approval

Daré Bioscience (DARE +5.8%), which saw it shares soar ~30% on Tuesday following FDA approval of Xaciato (clindamycin gel) for bacterial vaginosis, has seen a chunk of those gains evaporate since then. While shares are up again today, since Monday's close through this...

DARE - Penny Stocks to Watch: What's Going on With ZOM, DARE, PSFE, EFOI and AUUD Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are still a hot topic among retail traders and we’re covering some of the top ones to watch Wednesday that are on the move. Source: John Brueske/Shutterstock.com But before that, I do have to war...

DARE - Inotiv, Theravance Biopharma leads healthcare gainers; Radius Health, Ensysce Biosciences among major losers

Gainers: Inotiv (NASDAQ:NOTV) +13%, Theravance Biopharma (NASDAQ:TBPH) +11%, Biofrontera (NASDAQ:BFRA) +11%, Dare Bioscience (NASDAQ:DARE) +10%, Stereotaxis (NYSE:STXS) +8%. Losers: Radius Health (NASDAQ:RDUS) -43%, Ensysce Biosciences (NASDAQ...

DARE - CRDF, ATER and LEXX among pre market gainers

Energy Focus (NASDAQ:EFOI) +52% launches nUVo virus-targeted UVC air disinfectors to public. Lexaria Bioscience (NASDAQ:LEXX) +25% dehydraTECHTM-CBD reduces arterial stiffness, results confirmed in human clinical study HYPER-H21-2. Dare Bioscience (NASDAQ:DARE) +23% announces F...

DARE - Daré Announces FDA Approval of XACIATO(TM) (clindamycin phosphate) Vaginal Gel as a Treatment for Bacterial Vaginosis

Prescribing information supports positioning of XACIATO as a first line option for the treatment of bacterial vaginosis This marks the first FDA-approved product in Daré’s portfolio of potential first in category development candidates Strat...

DARE - Daré Bioscience wins FDA approval for XACIATO antibacterial gel

Daré Bioscience (DARE +10.5%) is trading sharply higher on the FDA approval of XACIATOTM (clindamycin phosphate) for the treatment of bacterial vaginosis in females aged 12 and above. In Q3 2021, the FDA had accepted the company’s marketing application for XACIATOTM with priority ...

DARE - Catalyst watch for next week: Rivian ratings pour in, big events for Southwest Airlines, McKesson and CVS Health

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

DARE - 3 Reddit Penny Stocks For Your Early December Watchlist

Are These Reddit Penny Stocks on Your List Right Now? If you’re looking for the best penny stocks to buy on Reddit, there’s no better time than right now. As a result of the major movement that is occurring in the stock market, there are plenty of opportunities to make m...

DARE - Daré Bioscience, Inc. 2021 Q3 - Results - Earnings Call Presentation

The following slide deck was published by Daré Bioscience, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Daré Bioscience, Inc. 2021 Q3 - Results - Earnings Call Presentation

DARE - Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2021 Results - Earnings Call Transcript

Daré Bioscience, Inc. (DARE) Q3 2021 Earnings Conference Call November 10, 2021, 04:30 PM ET Company Participants Sabrina Martucci Johnson - President and CEO John Fair - Chief Strategy Officer Lisa Walters-Hoffert - CFO Conference Call Participants Zegbeh Jallah - ROTH Capital Partners ...

Previous 10 Next 10